Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Yunlong Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Headquartered in Kunming, Yunnan Province, the company utilizes local botanical resources to develop treatments for cardiovascular, cerebrovascular, and respiratory diseases. Its flagship products include Dengzhan Shengmai Capsules and Xuanfei Zhike Particles, which are widely recognized in the Chinese domestic market. The company is listed on the National Equities Exchange and Quotations (NEEQ) and operates modern manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards. Yunnan Yunlong Pharmaceutical focuses on integrating traditional herbal wisdom with modern pharmaceutical technology to provide effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Yunlong Pharmaceutical.